A novel vaccine approach to stimulate class I restricted T cells.
Bennink
J R
JR
Laboratory of Viral Diseases, National Institute of Allergy and Infectious Diseases, Bethesda, MD 20892-0440, USA. jbennink@nih.gov
D000818:Animals; D001692:Biological Transport; D018414:CD8-Positive T-Lymphocytes / Q000276:immunology*; D019496:Cancer Vaccines / Q000494:pharmacology; D002462:Cell Membrane / Q000378:metabolism; D000939:Epitopes / Q000276:immunology / Q000378:metabolism; D015395:Histocompatibility Antigens Class I / Q000276:immunology*; D006801:Humans; D007156:Immunologic Memory; D051379:Mice; D010455:Peptides / Q000276:immunology / Q000378:metabolism; D014614:Vaccines, Synthetic / Q000494:pharmacology*; D014765:Viral Vaccines / Q000494:pharmacology
D019496:Cancer Vaccines; D000939:Epitopes; D015395:Histocompatibility Antigens Class I; D010455:Peptides; D014614:Vaccines, Synthetic; D014765:Viral Vaccines